Wilshire Completes Acquisition of Lyxor U.S.
SANTA MONICA, Calif.–(BUSINESS WIRE)–Wilshire, a leading global financial services firm, today announced the completion of its previously announced acquisition... Read more.
ICE Announces Approval of Electronic Trade Document Solution for the Delivery of Commodities Globally
LONDON–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology, and market infrastructure, today announced... Read more.
European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO... Read more.
EDF Australia commits Euro 10 million to Vast
SYDNEY & HOUSTON–(BUSINESS WIRE)–EDF Australia (“EDF Australia”) today announced a Euro 10 million commitment to Vast Renewables Limited (“Vast”),... Read more.
American Equity Celebrates 20th Anniversary of NYSE Listing
Rings NYSE Opening Bell to Commemorate Milestone on Friday, December 8th WEST DES MOINES, Iowa–(BUSINESS WIRE)–American Equity Investment Life Holding... Read more.
Global Hemoglobin A1C (HbA1C) Testing Strategic Research Report 2023: Market to Reach $2.3 Billion by 2030 from $1.4 Billion in 2022 – Benefits of POC HbA1c Tests Over Lab Tests Drives Adoption – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hemoglobin A1C (HbA1C) Testing – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.
Klas announces Kortex™ V, a mobile command post for decentralized decision making
DUBLIN–(BUSINESS WIRE)–Klas, a global leader in edge technology, announces the availability of Kortex V, a scalable mobile command post for decentralized... Read more.
Expro Group Holdings N.V. to Participate at the Goldman Sachs Energy, CleanTech and Utilities Conference
HOUSTON–(BUSINESS WIRE)–Expro Group Holdings N.V. (NYSE: XPRO) today announced that Michael Jardon, Chief Executive Officer, will participate in a panel... Read more.
United Partners and Vivactis Group Announce Strategic Collaboration
United Partners and Vivactis Group Forge Strategic Alliance to Elevate Healthcare Communication Standards SOFIA, Bulgaria–(BUSINESS WIRE)–#FutureOfHealthcareCommunications—United... Read more.
Merck and Eisai Provide Update on Phase 3 LEAP-001 Trial Evaluating (pembrolizumab) Plus LENVIMA® (lenvatinib) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma
RAHWAY, N.J., & NUTLEY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai... Read more.